The MenABCWY shot's importance to GSK's vaccine business has increased since ... narrowing its recommendations for both their products.

GSK is one of the pharma industry's top vaccine producers, giving Affinivax' shot the marketing muscle it will need to challenge Pfizer's Prevnar 13 and Prevnar 20 products – targeting 13 and 20 ...

We recently published a list of the 7 Most Undervalued Biotech Stocks To Invest In. In this article, we are going to take a ...

Moncef Slaoui, who ran the Operation Warp Speed Covid vaccine effort, is becoming chair of Curevo, a company developing a new ...

The FDA approved GSK's Penmenvy vaccine for ages 10-25, targeting five major meningococcal serogroups: A, B, C, W, and Y. Phase 3 trials with 4,800 participants showed the vaccine has a safety ...

Given the uncertainty around its top-line growth, short-term investors should exercise caution when investing in MRNA stock.

In mid-February, the FDA approved Penmenvy, a meningococcal vaccine, which I estimate will generate $1.2 billion in sales by 2029. In addition to GSK's 4. ... the dolutegravir products in the ...

The recommendations were made in a closed session with representatives from CBER, the CDC and Department of Defense.

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

GSK reports under three segments: Specialty Medicines, Vaccines and General Medicines ... The growth of these products comes from strong patient demand. These two long-acting medicines contributed ...